Ritonavir (Norvir): News
- Ritonavir Price Increase Responses (Regularly Updated)
To help its members remain informed, the Academy has compiled the following list of letters from various organizations and groups of providers responding to the price increase.
From American Academy of HIV Medicine
- Updated Information on Drug Interactions Between Victrelis (Boceprevir) and Certain Boosted HIV Protease Inhibitor Drugs (April 26, 2012)
From U.S. Food and Drug Administration
- Norvir (Ritonavir) Labeling Revised to Include New Warnings on Side Effects, Drug Interactions (December 7, 2011)
From U.S. Food and Drug Administration
- New FDA Warning on HIV Drugs Invirase and Norvir (February 24, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- FDA Approves New Tablet Formulation of Norvir (Ritonavir) (February 10, 2010)
From U.S. Food and Drug Administration
- New Drug Interactions for Norvir (January/February 2010)
In Positively Aware, from Test Positive Aware Network
- New Heat-Stable Form of Norvir Approved (February 2010)
To read PDF, click here.
From Project Inform
- Important Label Update for Norvir (Ritonavir) (November 23, 2009)
From U.S. Food and Drug Administration
- Federal Appeals Court Rejects Lawsuit Against Abbott Over HIV/AIDS Drug Price Hike (July 8, 2009)
In Kaiser Daily U.S. HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Updated Labeling for Norvir (Ritonavir) Soft Capsule and Oral Solution (September 2, 2008)
From U.S. Food and Drug Administration
- Newly-Unsealed Documents Shed Light on Abbott Labs' 400% Norvir Price Hike (May 12, 2008)
Union, consumer groups decry Abbott for putting profits before HIV/AIDS patients' needs
In A Closer Walk: A Film by Robert Bilheimer, from Community Catalyst
- Glaxo Joins Lawsuit Against Abbott Over Price of Norvir (November 12, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Pharmacies, Drug Wholesaler File Lawsuit Against Abbott Over Norvir Price (October 30, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- New Dosing Regimen for Lexiva Approved (October 12, 2007)
From U.S. Food and Drug Administration
- Interaction Warning: Ritonavir and Blood-Pressure Drug Nifedipine (December 12, 2006)
From aidsmap.com
- FDA Approves Pediatric Dosing for Ritonavir (October 6, 2005)
From U.S. Food and Drug Administration
- Norvir (Ritonavir) 100 mg Now Available in 30-Count Bottle (May 13, 2005)
From U.S. Food and Drug Administration
- AIDS Treatment Activists Coalition: AIDS Activists Outraged by Abbott Settlement With AIDS Healthcare Foundation (July 16, 2004)
To read PDF, click here.
From AIDS Treatment Activists Coalition
- Food and Drug Administration Warning Letter to Abbott Laboratories (PDF) (June 10, 2004)
The FDA warns Abbott Laboratories that some of its marketing of its AIDS drug ritonavir (Norvir) in certain patient information materials is false and misleading.
From U.S. Food and Drug Administration
- Ritonavir Sales Projected to Top $2B in Next Decade; Insurers' Costs Skyrocket (June 7, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Aetna Files Lawsuit Against Abbott Over 400% Price Increase of Ritonavir (May 27, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
|
Advertisement
|
Email
Glossary
